S. Kesten

发表

Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH).

B. Cravatt, J. Dunbar, Yun-Song Song, 2009, Bioorganic & medicinal chemistry letters.

4-bromo-1-methoxy-N-[2-(4-aryl-1-piperazinyl)ethyl]-2-naphthalenecarboxamides: Selective dopamine D3 receptor partial agonists

Stephen J. Johnson, T. Heffner, H. Akunne, 1996 .

Isoindolinone enantiomers having affinity for the dopamine D4 receptor.

T. Heffner, J. Rubin, L. Wise, 1998, Bioorganic & medicinal chemistry letters.

Design, synthesis, and evaluation of chromen-2-ones as potent and selective human dopamine D4 antagonists.

T. Heffner, L. Wise, T. Pugsley, 1999, Journal of medicinal chemistry.

A novel modification of the Ritter reaction using trimethylsilyl cyanide

J. Knobelsdorf, S. Kesten, O. P. Goel, 1996 .

Subtype-selective N-methyl-D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(heteroarylalkynyl)-4-benzylpiperidines.

S. Espitia, L. Wise, E. R. Whittemore, 2001, Journal of medicinal chemistry.

The efficient synthesis of (3R,4R,5R)-3-amino-4,5-dimethyl-octanoic acid, a chiral β-amino acid with potent affinity for the α2δ protein

Paul D. Johnson, A. Thorpe, J. Schwarz, 2009 .

Aminopyrimidines with high affinity for both serotonin and dopamine receptors.

T. Heffner, H. Akunne, L. Wise, 1998, Journal of medicinal chemistry.

Subtype selective NMDA receptor antagonists: evaluation of some novel alkynyl analogues.

Jon L. Wright, L. Meltzer, S. Nikam, 2004, Bioorganic & medicinal chemistry letters.

Novel cyclohexyl amides as potent and selective D3 dopamine receptor ligands

J. Rubin, H. Akunne, L. Wise, 1997 .

2-(aminoalkyl)-5-nitropyrazolo[3,4,5-kl]acridines, a new class of anticancer agents.

J. Dunbar, J. Plowman, D. Ward, 1992, Journal of medicinal chemistry.

Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor.

Shobha N. Bhattachar, B. Cravatt, D. T. Dudley, 2011, ACS medicinal chemistry letters.

The design and synthesis of human branched-chain amino acid aminotransferase inhibitors for treatment of neurodegenerative diseases.

R. T. Carroll, Xiaohong Liu, J. Rubin, 2006, Bioorganic & medicinal chemistry letters.